» Articles » PMID: 20348922

Toll-like Receptor 4 and High-mobility Group Box-1 Are Involved in Ictogenesis and Can Be Targeted to Reduce Seizures

Overview
Journal Nat Med
Date 2010 Mar 30
PMID 20348922
Citations 421
Authors
Affiliations
Soon will be listed here.
Abstract

Brain inflammation is a major factor in epilepsy, but the impact of specific inflammatory mediators on neuronal excitability is incompletely understood. Using models of acute and chronic seizures in C57BL/6 mice, we discovered a proconvulsant pathway involving high-mobility group box-1 (HMGB1) release from neurons and glia and its interaction with Toll-like receptor 4 (TLR4), a key receptor of innate immunity. Antagonists of HMGB1 and TLR4 retard seizure precipitation and decrease acute and chronic seizure recurrence. TLR4-defective C3H/HeJ mice are resistant to kainate-induced seizures. The proconvulsant effects of HMGB1, like those of interleukin-1beta (IL-1beta), are partly mediated by ifenprodil-sensitive N-methyl-d-aspartate (NMDA) receptors. Increased expression of HMGB1 and TLR4 in human epileptogenic tissue, like that observed in the mouse model of chronic seizures, suggests a role for the HMGB1-TLR4 axis in human epilepsy. Thus, HMGB1-TLR4 signaling may contribute to generating and perpetuating seizures in humans and might be targeted to attain anticonvulsant effects in epilepsies that are currently resistant to drugs.

Citing Articles

Adolescent binge alcohol exposure accelerates Alzheimer's disease-associated basal forebrain neuropathology through proinflammatory HMGB1 signaling.

Fisher R, Matheny L, Ankeny S, Qin L, Coleman Jr L, Vetreno R Front Aging Neurosci. 2025; 17:1531628.

PMID: 40046779 PMC: 11880232. DOI: 10.3389/fnagi.2025.1531628.


Mechanistic insight of curcumin: a potential pharmacological candidate for epilepsy.

Khatoon S, Kalam N Front Pharmacol. 2025; 15():1531288.

PMID: 39845785 PMC: 11752882. DOI: 10.3389/fphar.2024.1531288.


Ablation of CCL17-positive hippocampal neurons induces inflammation-dependent epilepsy.

Eberhard J, Henning L, Fulle L, Knopper K, Bohringer J, Graelmann F Epilepsia. 2024; 66(2):554-568.

PMID: 39607395 PMC: 11827734. DOI: 10.1111/epi.18200.


High Translocation of High Mobility Group Box 1 in the Brain Tissue of Patients with Sturge-Weber Syndrome.

Cheng Z, Li X, Wang S, Sun W, Pan J, Wang X J Inflamm Res. 2024; 17:9347-9358.

PMID: 39588143 PMC: 11587792. DOI: 10.2147/JIR.S473377.


Role of inflammasomes and neuroinflammation in epilepsy.

Hollis A, Lukens J Immunol Rev. 2024; 329(1):e13421.

PMID: 39523682 PMC: 11744240. DOI: 10.1111/imr.13421.


References
1.
Macagno A, Molteni M, Rinaldi A, Bertoni F, Lanzavecchia A, Rossetti C . A cyanobacterial LPS antagonist prevents endotoxin shock and blocks sustained TLR4 stimulation required for cytokine expression. J Exp Med. 2006; 203(6):1481-92. PMC: 2118317. DOI: 10.1084/jem.20060136. View

2.
Vezzani A, Moneta D, Conti M, Richichi C, Ravizza T, De Luigi A . Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice. Proc Natl Acad Sci U S A. 2000; 97(21):11534-9. PMC: 17235. DOI: 10.1073/pnas.190206797. View

3.
Balosso S, Maroso M, Sanchez-Alavez M, Ravizza T, Frasca A, Bartfai T . A novel non-transcriptional pathway mediates the proconvulsive effects of interleukin-1beta. Brain. 2008; 131(Pt 12):3256-65. PMC: 2724908. DOI: 10.1093/brain/awn271. View

4.
Ravizza T, Gagliardi B, Noe F, Boer K, Aronica E, Vezzani A . Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy. Neurobiol Dis. 2007; 29(1):142-60. DOI: 10.1016/j.nbd.2007.08.012. View

5.
Park J, Svetkauskaite D, He Q, Kim J, Strassheim D, Ishizaka A . Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem. 2003; 279(9):7370-7. DOI: 10.1074/jbc.M306793200. View